SA’s Missing Middle Faces Growing Healthcare Crisis
Discover the implications of SA's missing middle, where rising medical scheme costs leave many without adequate healthcare options.
Discover the implications of SA's missing middle, where rising medical scheme costs leave many without adequate healthcare options.
GLP-1 Drugs In SA could spread as cheaper generics and oral pills arrive, changing food and alcohol demand and pushing premium health trends.
Biovac vaccine tender secures a vital R5.3bn state contract for Hexaxim, driving Africa's local manufacturing goals.
South Africa's Lenacapavir rollout begins on June 5, 2026, offering a new HIV prevention tool in high-burden districts.
Discover the benefits of the Africa Vaccine Procurement Framework for vaccine manufacturing and demand aggregation in Africa.